State of Wisconsin Investment Board
FOLD

State of Wisconsin Investment Board’s Amicus Therapeutics FOLD Stock Holding History

State of Wisconsin Investment Board’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.04M Sell
140,812
-43,522
-24% -$624K ﹤0.01% 1394
2025
Q4 		$2.62M Sell
184,334
-307,612
-63% -$3.02M 0.01% 1307
2025
Q3 		$3.88M Sell
491,946
-12,182
-2% -$86.7K 0.01% 1054
2025
Q2 		$2.89M Buy
504,128
+97,185
+24% +$627K 0.01% 1136
2025
Q1 		$3.32M Buy
406,943
+129,773
+47% +$1.2M 0.01% 1066
2024
Q4 		$2.61M Sell
277,170
-49,153
-15% -$511K 0.01% 1185
2024
Q3 		$3.49M Sell
326,323
-23,520
-7% -$256K 0.01% 1099
2024
Q2 		$3.47M Buy
349,843
+43,229
+14% +$444K 0.01% 1076
2024
Q1 		$3.61M Buy
306,614
+131,595
+75% +$1.68M 0.01% 1063
2023
Q4 		$2.48M Sell
175,019
-3,094
-2% -$35.1K 0.01% 1193
2023
Q3 		$2.17M Sell
178,113
-6,466
-4% -$83.4K 0.01% 1232
2023
Q2 		$2.32M Sell
184,579
-9,795
-5% -$116K 0.01% 1258
2023
Q1 		$2.16M Sell
194,374
-17,058
-8% -$210K 0.01% 1278
2022
Q4 		$2.58M Sell
211,432
-13,006
-6% -$146K 0.01% 1245
2022
Q3 		$2.34M Sell
224,438
-13,820
-6% -$154K 0.01% 1300
2022
Q2 		$2.56M Sell
238,258
-107,842
-31% -$888K 0.01% 1299
2022
Q1 		$3.28M Hold
346,100
– – 0.01% 1317
2021
Q4 		$4M Hold
346,100
– – 0.01% 1108
2021
Q3 		$3.31M Hold
346,100
– – 0.01% 1163
2021
Q2 		$3.34M Hold
346,100
– – 0.01% 1167
2021
Q1 		$3.42M Sell
346,100
-10,300
-3% -$159K 0.01% 1124
2020
Q4 		$8.23M Sell
356,400
-51,500
-13% -$1.05M 0.02% 771
2020
Q3 		$5.76M Hold
407,900
– – 0.01% 887
2020
Q2 		$6.15M Buy
407,900
+13,100
+3% +$160K 0.02% 808
2020
Q1 		$3.65M Buy
394,800
+48,500
+14% +$461K 0.01% 896
2019
Q4 		$3.37M Hold
346,300
– – 0.01% 1041
2019
Q3 		$2.78M Buy
346,300
+74,700
+28% +$811K 0.01% 962
2019
Q2 		$3.39M Buy
271,600
+6,000
+2% +$76.1K 0.01% 914
2019
Q1 		$3.61M Buy
265,600
+70,200
+36% +$858K 0.01% 889
2018
Q4 		$1.87M Buy
195,400
+2,600
+1% +$28.6K 0.01% 984
2018
Q3 		$2.33M Hold
192,800
– – 0.01% 1013
2018
Q2 		$3.01M Buy
192,800
+28,700
+17% +$434K 0.01% 940
2018
Q1 		$2.47M Hold
164,100
– – 0.01% 940
2017
Q4 		$2.36M Buy
164,100
+59,100
+56% +$812K 0.01% 956
2017
Q3 		$1.58M Hold
105,000
– – ﹤0.01% 991
2017
Q2 		$1.06M Buy
+105,000
New +$845K ﹤0.01% 1058

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State of Wisconsin Investment Board's FOLD Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Amicus Therapeutics (FOLD) stake by 24% in Q1 2026, selling an estimated $624K and leaving 140,812 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1394.

State of Wisconsin Investment Board first reported a position in FOLD in Q2 2017 and has held it in 36 quarters since. The position peaked at $8.23M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • State of Wisconsin Investment Board held 140,812 shares of Amicus Therapeutics worth $2.04M as of Q1 2026.
  • State of Wisconsin Investment Board sold 43,522 Amicus Therapeutics shares in Q1 2026, an estimated $624K.
  • Amicus Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1394 holding.
  • State of Wisconsin Investment Board first reported a position in Amicus Therapeutics in Q2 2017 and has held it in 36 quarters since.
  • State of Wisconsin Investment Board's Amicus Therapeutics position peaked at $8.23M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.